Elicio Therapeutics News

JonesTrading Maintains Elicio Therapeutics(ELTX.US) With Buy Rating, Maintains Target Price $9

Moomoo NewsNov 14 11:31 ET

JonesTrading Maintains Elicio Therapeutics(ELTX.US) With Buy Rating, Maintains Target Price $9

Moomoo NewsNov 8 13:31 ET

Elicio Therapeutics Analyst Ratings

BenzingaOct 31 07:15 ET

JonesTrading Initiates Elicio Therapeutics(ELTX.US) With Buy Rating, Announces Target Price $9

Moomoo NewsOct 30 16:31 ET

Elicio Therapeutics Price Target Maintained With a $10.00/Share by HC Wainwright & Co.

Dow JonesAug 23 08:16 ET

Elicio Therapeutics Analyst Ratings

BenzingaAug 23 08:07 ET

H.C. Wainwright Maintains Elicio Therapeutics(ELTX.US) With Buy Rating, Maintains Target Price $10

Moomoo NewsAug 23 06:33 ET

Elicio Therapeutics Analyst Ratings

BenzingaJun 6 06:50 ET

Elicio Therapeutics Analyst Ratings

BenzingaMay 22 06:38 ET

HC Wainwright & Co. Reiterates Buy on Elicio Therapeutics, Maintains $10 Price Target

BenzingaMay 22 06:38 ET

Analysts Have Conflicting Sentiments on These Healthcare Companies: Ionis Pharmaceuticals (IONS) and Elicio Therapeutics (ELTX)

TipRanksMay 17 08:05 ET

Elicio Therapeutics Analyst Ratings

BenzingaMay 1 06:18 ET

Elicio Therapeutics Analyst Ratings

BenzingaApr 1 09:24 ET

Elicio Therapeutics Analyst Ratings

BenzingaJan 17 06:23 ET

Buy Rating Upheld for Elicio Therapeutics Amid Solid Financial Position and Promising Clinical Results

TipRanksNov 13, 2023 06:18 ET

Elicio Therapeutics Analyst Ratings

BenzingaOct 26, 2023 08:23 ET

H.C. Wainwright Reiterates Their Hold Rating on Angion Biomedica (ANGN)

TipRanksJul 26, 2022 06:30 ET

Angion Biomedica Cut to Neutral From Buy by HC Wainwright & Co.

Dow JonesJul 18, 2022 06:22 ET

Angion Biomedica analyst ratings

Benzinga Analyst RatingsJul 18, 2022 06:14 ET

Oppenheimer Downgrades Angion Biomedica to Perform From Outperform, Removes $8 Price Target

MT NewswiresJun 30, 2022 21:57 ET